Tania Armstrong-Whitworth
Stock Analyst at Canaccord Genuity
(3.81)
# 1,989
Out of 5,116 analysts
145
Total ratings
43.6%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by Tania Armstrong-Whitworth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: CRRX CareRx Corporation | Reiterated: Buy | $3.50 → $4.00 | $3.10 | +29.03% | 9 | Nov 6, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Reiterated: Buy | $9.50 → $12.75 | $11.42 | +11.65% | 24 | Nov 6, 2026 | |
| TSXV: WSTR WELLSTAR Technologies Corp. | Initiated Coverage: Buy | $8.50 | $5.93 | +43.34% | 1 | Oct 14, 2026 | |
| TSXV: NURS Hydreight Technologies Inc. | Reiterated: Buy | $6.75 | $3.00 | +125.00% | 1 | Sep 2, 2026 | |
| TSXV: DMGI DMG Blockchain Solutions Inc. | Downgraded: Hold | $0.40 → $0.55 | $0.37 | +48.65% | 5 | Aug 27, 2026 | |
| TSX: JWEL Jamieson Wellness Inc. | Downgraded: Hold | $43.50 → $45.75 | $45.64 | +0.24% | 17 | Aug 10, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $42.00 | $34.48 | +21.81% | 1 | Jul 13, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $1.25 → $19.00 | $10.12 | +87.75% | 5 | May 21, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Initiated Coverage: Hold | $4.00 → $5.00 | $4.41 | +13.38% | 20 | May 19, 2026 | |
| TSX: EXE Extendicare Inc. | Reiterated: Buy | $13.00 → $22.50 | $27.61 | -18.51% | 2 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13.50 → $12.25 | $3.45 | +255.07% | 3 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9.00 | $9.71 | n/a | 5 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13.00 → $14.00 | $13.51 | n/a | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 → $19.50 | $19.23 | n/a | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.65 | $5.12 | n/a | 18 | Jul 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $18 | $33.27 | n/a | 12 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Buy | $3.50 → $3.00 | $1.01 | n/a | 14 | Jun 28, 2022 |
CareRx Corporation
Nov 6, 2026
Reiterated: Buy
Price Target: $3.50 → $4.00
Current: $3.10
Upside: +29.03%
Knight Therapeutics Inc.
Nov 6, 2026
Reiterated: Buy
Price Target: $9.50 → $12.75
Current: $11.42
Upside: +11.65%
WELLSTAR Technologies Corp.
Oct 14, 2026
Initiated Coverage: Buy
Price Target: $8.50
Current: $5.93
Upside: +43.34%
Hydreight Technologies Inc.
Sep 2, 2026
Reiterated: Buy
Price Target: $6.75
Current: $3.00
Upside: +125.00%
DMG Blockchain Solutions Inc.
Aug 27, 2026
Downgraded: Hold
Price Target: $0.40 → $0.55
Current: $0.37
Upside: +48.65%
Jamieson Wellness Inc.
Aug 10, 2026
Downgraded: Hold
Price Target: $43.50 → $45.75
Current: $45.64
Upside: +0.24%
Apotex Health Corp.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $42.00
Current: $34.48
Upside: +21.81%
Satellos Bioscience Inc.
May 21, 2026
Initiated Coverage: Buy
Price Target: $1.25 → $19.00
Current: $10.12
Upside: +87.75%
HLS Therapeutics Inc.
May 19, 2026
Initiated Coverage: Hold
Price Target: $4.00 → $5.00
Current: $4.41
Upside: +13.38%
Extendicare Inc.
Dec 4, 2025
Reiterated: Buy
Price Target: $13.00 → $22.50
Current: $27.61
Upside: -18.51%
Nov 14, 2025
Reiterated: Buy
Price Target: $13.50 → $12.25
Current: $3.45
Upside: +255.07%
Sep 2, 2025
Reiterated: Buy
Price Target: $9.00
Current: $9.71
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $13.00 → $14.00
Current: $13.51
Upside: n/a
Nov 5, 2024
Reiterated: Buy
Price Target: $18.00 → $19.50
Current: $19.23
Upside: n/a
Jul 4, 2024
Reiterated: Buy
Price Target: $3.00 → $2.65
Current: $5.12
Upside: n/a
Nov 21, 2022
Reiterated: Buy
Price Target: $22 → $18
Current: $33.27
Upside: n/a
Jun 28, 2022
Downgraded: Buy
Price Target: $3.50 → $3.00
Current: $1.01
Upside: n/a